fects in many body tissues by binding to their respective receptors.
The search for possible crosstalking mechanisms in overlapping target cells led to the discovery of synergism between a thyroid hormone receptor-binding site and a cryptic glucocorticoid-responsive element. Glucocorticoid responsiveness could only be detected in the presence of thyroid hormone and its receptor. This synergism requires the glucocorticoid receptor (GR) DNA-binding domain and is mediated by the transactivation domains. We found that synergism also occurs when the thyroid hormone receptor is replaced by the retinoic acid receptor or the GR is replaced by the progesterone receptor. Synergism is qualitatively independent of the type of thyroid hormone receptor-binding site and promoter. In several combinations of promoter and response elements, including a retinoic acid response element, T3 induction was only seen in the presence of the cryptic glucocorticoid-responsive element, GR, and glucocorticoids.
(Molecular Endocrinology 8: [440] [441] [442] [443] [444] [445] [446] [447] 1994) including synergism between neighboring DNA-bound factors (8-l 5).
Our results demonstrate that the simultaneous presence of GR and TR in the nucleus results in synergism between the two receptors, thereby changing the response specificity of a target gene. A reporter gene regulated by a TR-binding site (T3RE) confers glucocorticoid responsiveness in addition to and dependent on a thyroid hormone response. The glucocorticoid action is mediated by a cryptic glucocorticoid-responsive element (GRE), which is nonfunctional unless tested in conjunction with a canonical T3RE.
INTRODUCTION
Almost all mammalian tissues respond to glucocorticoids. This glucocorticoid effect is mediated by glucocorticoid receptor (GR), which binds to a large set of target genes and thereby acts as a ligand-inducible transcription factor (l-3). Similarly, thyroid hormones bind to thyroid hormone receptor (TR), influencing development and general metabolism in nearly every cell type by regulating specific genes (2, 4, 5) . Except for the subcellular location of both ligand-free receptors (TR in the nucleus and GR in the cytoplasm), both function similarly, and both have homologous structures (6,7). Therefore, we wondered whether GR and TR act independently from each other or whether there might be some kind of communication between both receptors. Possible "cross-talking" mechanisms have been shown for a limited number of transcription factors,
To study the combined gene regulation of GR and TR, we cotransfected expression vectors coding for the rat TRtv and the human GRLu. Their effect on gene regulation with or without the corresponding ligands was determined using a reporter gene consisting of the thymidine kinase (tk) promoter and the chloramphenicol acetyltransferase (CAT) gene. Binding sites for the receptors were inserted in front of the tk promoter (see Fig. 2C ). Transfections were performed using the human mammary carcinoma cell line T47D, which is capable of eliciting high hormonal responses.
ossa-&309/94/0440-0447$03.00/0 Molecular Endocrinology Copynght 0 1994 by The Endocrme Scmety Expression of the tkCAT gene construct containing the chicken lysozyme T3RE (GREc-T,RElys-tkCAT; see below) was induced g-fold by the addition of T3 hormone (Fig. la) in the presence of rat (r) TRcv and human (h) GRcu. In contrast, the addition of dexamethasone (dex) alone had no effect. The combination of both hormones resulted in a very high (go-fold) induction of transcription, suggesting a synergistic action between the two hormone receptors. Detailed sequence analysis of the reporter plasmid revealed the presence of an element resembling a GRE (see also Fig. 2C ) located 265 basepairs (bp) up-stream of the T,RElys. Binding assays using a consensus palindromic GRE, the 38-bp Neil fragment containing the GRE-like element, or various other vector fragments as competitors demonstrated GR binding to the Neil fragment (see also Fig. 2) . We termed the element located in this fragment a cryptic GRE (GREc), because it is unable to mediate glucocorticoid responsiveness in the absence of TB hormone. Deletion of up-stream sequences including the GREc did not abrogate TB inducibility, but abolished the synergistic GR effect (Fig. 1 b) , indicating that the cryptic binding site is required for GR/TR synergism. In fact, the addition of dex leads to a weak decrease in TJ induction, possibly due to a squelching effect in the presence of both hormones. As the ligand-free TR is able to repress transcription, we investigated whether the observed T3/dex effect is due to stimulation or to a release of repression. Therefore, we used a reporter plasmid containing a mutation in the T3RE so that the T3 receptor cannot bind (GREc-T,REmut-tkCAT; see Materials and Methods). The basal level in the absence of hormone was similar to that obtained with GREc-T,RElys-tkCAT, indicating that this low basal level is not due to repression via the T,RElys. Neither the separate addition of each hormone nor the combination of both hormones resulted in a detectable induction of GREc-T3REmut-tkCAT ( Fig. 1 c) , stressing the absolute requirement of the T3RE for the observed effects.
Our data indicate a synergistic effect between T,RElys and GREc. The synergism requires both binding sites, although the GREc is nonfunctional when tested alone.
The relative orientation of the two receptors or the distance between the binding sites is not crucial for the synergistic effect. A reporter construct (GREc+4-T,RElys-tkCAT) containing a 4-bp insertion, i.e. about half a helical turn, between GREc and T,RElys displayed the same inducibility as the original construct (Fig. Id) . This result suggests that a strict spatial ar- rangement of the GR or TR is not required for GR/TR synergism.
Cryptic GRE Weakly Binds the Receptor
To ensure that the cryptic GRE is able to bind GR, we performed gel retardation experiments. As the GREc is unable to mediate GR inducibility on its own, and the homology to known GREs is less than 60% (Fig. 2C) , we expected the binding to be weak compared to that of a consensus palindromic GRE. Therefore, we used the bacterially expressed DNA-binding domain (GR-DBD; amino acids 370-503) of hGR, which is present in large amounts in crude bacterial extracts. This protein contains the zinc finger domain of the GR, which is sufficient for specific GRE binding of the receptor (16) (17) (18) (19) . Incubation of extracts containing GR-DBD with a labeled GREpal probe led to the formation of a protein-DNA complex ( Fig. 2A, lane 3 ). This complex is specific for the expressed GR-DBD, as neither extracts from nontransformed bacteria nor extracts from transformed bacteria in the absence of inducer (IPTG) produced a similar complex (Fig. 2 , lanes 1 and 2, respectively). Similarly, a specific complex was formed using a GREc probe and the GR-DBD-containing extracts (lane 6) but not with control extracts (lanes 4 and 5). As expected, this complex was much weaker than that obtained with GREpal. Densitometric scanning analysis of the autoradiograms revealed roughly a 400-to 500-fold lower affinity of the GR-DBD for GREc compared to GREpal. It should be stressed that for GREpal, the amount of protein extract used was lo-fold less than that for GREc. The complexes shown are not due to nonspecific DNA binding of the GR-DBD, as incubation of the same extracts with an unrelated DNA sequence containing a GAL-4-binding site did not give rise to any complex, even after a lo-fold longer exposure of the gel (Fig. 28 , lanes 2-4). Taken together, these results show that the GREc sequence at position -265 is able to bind the GR weakly. Interestingly, the complex formed with GREc migrates faster in the gel than the GREpal complex, despite the fact that the probe is somewhat longer, suggesting.a different arrangement of the GR on this weak binding site.
Synergism Depends on the Transactivation Function of the GR and Requires the DBD of the Receptor
We wanted to localize the GR domains required for synergism. In the first set of transfection experiments, mutants of the GR were cotransfected with 0.1 pmol TR expression plasmid. Their ability to synergize with TR (fold synergism) was compared to their transactivation capacity (fold induction), determined by cotransfecting the mutants with the reporter GREc-(GREpal)xBtkCAT (18) containing a highly inducible glucocorticoid-responsive unit. The hormone-binding domain of the GR was deleted (Fig. 4) generating constitutively active transcription factors (17). Thus, the addition of dex can be avoided, and possible effects of the endogenous GR can be excluded. Synergism was measured by comparing the T,-induced CAT values without and with cotransfection of the GR mutants. As demonstrated in Fig. 3A deletion more strongly affected transactivation (1 OOfold, compare l-51 5 to 262-515) than the deletion of 72 (lo-fold; compare l-550 to 1-515 or 262-550 to 262-515). The GR/TR synergism mediated by GR mutants containing only one transactivation domain was similarly low. When the complete DBD of the GR mutants was replaced by that of the yeast transcription factor GAL4, the resulting fusion protein completely lost its synergizing capability (Fig. 3A) . To assess more specifically the role of the GR DNA-binding function, a DNA binding-deficient mutant was tested. Mutant l-550/G441 carries a deletion of the hormone-binding domain and a C to G conversion at position 441 located in the first zinc finger, which completely abolishes the DNA-binding ability (17). Figure 38 shows that this mutant is unable to mediate both transactivation and synergism with TR, in contrast to the constitutive activity of mutant l-550.
These data show that transactivation and synergism with TR mediated by GR require the same GR domains. On the other hand, the absolute requirement for the DBD of GR agrees with the involvement of the cryptic binding site GREc.
Progesterone
and Retinoic Acid (RA) Receptor (RAR) Can Replace GR or TR, Respectively
To assess the general validity of the observed synergism, we first tested whether the participating hormone receptors can be replaced by other members of the steroid receptor superfamily. First we asked whether the progesterone receptor (PR), which normally displays the same binding specificity as the GR, would be able to synergize with TR. The data presented in Fig.  4a show that the GR can functionally be replaced by the endogenous PR of the T47D cells (addition of progestin R5020 at 0.01 PM) to reproduce the synergistic effect. Thus, like the GR, the PR is unable to mediate induction via the GREc alone, but strongly synergizes with the T,-activated TR. Additionally, a reporter plasmid containing a naturally occurring RA response element (RARE), DR5 (20, 21) was used to test whether the hRARcv (22) is able to substitute for TR in synergism with GR. Cotransfection of GR and hRARa expression vectors with GREc-DR5-tkCAT produced a 30-fold induction of transcription by RA alone (Fig. 4b) . The addition of both ligands, dex and RA, led to a 3-fold increase in induction.
Several Different TREs Are Able to Mediate Synergism
In the next set of experiments we investigated whether the synergistic response obtained by the combined action of TR and GR is restricted to the inverted palindromic structure of the chicken lysozyme T3RE. Thus, we compared the different TR-binding sequences T,RElys, T,REpal (23) T,RElap (24) and the direct repeat DR4 (20, 21) for their ability to confer synergism in combination with TR and GR (0.1 pmol rTRcv and 0.1 pmol hGRcu). The results shown in Fig. 5 clearly demonstrate that the orientation of the palindromic T3RE half-sites does not play a major role, resulting in only a marginal quantitative difference. The high transcriptional activity of GREc-DRCtkCAT in the presence of both hormones probably results from the already high T3 response of this construct.
Different Promoters Respond to GR-TR Synergism
To test whether the HSV-tk promoter sequences are required for the GR/TR synergistic response, we con- GREc-TaREpal-, GREc TaRElap-tk-CAT (24) and GREc-DR4-tkCAT with the indicated expression plasmids were carried out (see Fig. 1 ).
MOL ENDO. 1994 444 Vol8 No. 4 strutted a set of four additional reporter plasmids. The tk promoter sequences were replaced by two other viral core promoters [simian virus-40 (SV40) early and adenovirus major late promoters], by the basal promoter of the human cY-globin gene, or by the human metallothionein-II gene (Fig. 6A) . The chicken lysozyme T$tE was inserted in the SalI site of the polylinker, and all constructs were tested for synergism using identical conditions (0.1 pmol rTRa and 0.1 pmol hGRa). The results from this set of transfection experiments are presented in Fig. 6B . All promoters produced a synergistic response, extending the general validity of GR/ TR synergism. These experiments demonstrate the difference in the magnitude between single induction and synergism. Two of the T3RE promoter combinations tested (GREc-T,RElys-glob-CAT and GREc-T,RElys-adeno-CAT)
did not respond to the addition of thyroid hormone or dex, respectively. Only the combined administration of both hormones resulted in an induction of approximately 250-fold, in contrast to the about 28fold synergistic induction (T3 vs. dex plus T3) observed for the three other promoters.
This result defines a new type of glucocorticoid-responsive unit: T3RE containing promoters insensitive to TB induction functionally respond to glucocorticoids in the presence of TB and a cryptic GRE.
Synergism Occurs in Different Cell Lines
To test whether the synergism between GR and TR is a cell-specific effect, the reporter plasmid GREc-T,REglob-CAT was transfected together with expression plasmids for TR and GR into additional cell lines. In MCF-7 cells, a human mammary carcinoma line, a strong synergism was seen compared to the basal level obtained with single hormone addition, although CAT activity in the presence of both hormones was lower than that in T47D cells (Fig. 7) . In CVl cells, the CAT activity was much lower, but a clear TB induction, depending on the presence of dex, was detected.
Synergism Alters the Specificity of Responsive Elements
As shown in Fig. 8a , the RA-induced activation of the RAR on a DR5, a naturally occurring RARE, containing reporter plasmid could be increased 3-fold by simultaneous addition of Dex. We were interested in the effect of TR on such a reporter plasmid. It had been shown that TR is able to bind to a DR5 element, but cannot transactivate this RARE (20, 21). We cotransfected a T47D MCF7 CVl GREc-DR5-tk-CAT reporter plasmid with expression plasmids for rTRa and hGRa: (Fig. 8b) . As expected, no TI induction could be seen. The addition of glucocorticoids alone could not activate transcription, as shown in all previous cases. Induction of both receptors resulted in the activation of transcription comparable to that of the RAR shown in Fig. 8a . By the synergistic action of two receptors, which alone are unable to activate this gene, the specificity of the RARE is overruled, and TR can mediate activation through this element in the presence of GR.
DISCUSSION
The effects of steroids and thyroid hormones on development, differentiation, and gene regulation have been intensively studied. Thyroid hormones and the glucocorticoid cortisol were the first hormones to be purified and characterized. In fact, most body tissues respond to these hormones. Therefore, the simultaneous action conferred by the receptors for both hormones is the rule rather than an exception.
Here we show that the presence of a cryptic GRE is able to mediate a strong synergism between TR and GR. Several lines of evidence illustrate the requirement for specific DNA binding of GR in synergism. Changing the DNA binding specificity of the GR by switching to the GAL4 DBD or destroying the DNA binding of the GR by a point mutation abolished the effect. Deletion of the GREc in the CAT vector resulted in a loss of synergistic activation. Finally, we could show that this DNA element binds the GR in vitro, although with a very low affinity. It is unclear whether the slightly different electrophoretic mobility of the GR/GREc complex compared to that of the GR/GREpal reflects a different binding geometry of the receptor to these elements, as was described for a negative GRE in the POMC gene (25). Very importantly, the presence of the GREc could only be functionally detected in the presence of a consensus receptor-binding site, a TBRE or RARE. This underscores the importance of weak binding sites that show strong activities in the presence of other elements, in our case mediating a thyroid hormone-dependent glucocorticoid induction.
We believe that the phenomenon of synergism explains the cooperative effect of the two hormones seen in several cases. For example, the rat phosphoenolpyruvate carboxykinase gene requires both hormones for induction (26). Furthermore, synergism may explain how T3 induction of the GH gene can be potentiated by glucocorticoids. Either TB or RA is required to mediate glucocorticoid induction of the GH gene (27, 28). Multiple T,REs have been found in the rat GH gene (29) whereas a GRE has not been identified. Also, the concentration of TR is not changed by glucocorticoid induction (30). Thus, GH induction may be mediated by synergism of a cryptic GRE with the T3RE sequences.
In addition to increasing the T3 stimulus, synergism increases the number of GR-inducible genes, as TBinducible genes containing cryptic GREs may be inducible by glucocorticoids as well. This effect is very striking for promoters that contain a T3RE but are minimally T3 responsive, as we have demonstrated in two cases. In addition, we showed that an otherwise unresponsive TR-binding site (DR5), which is a specific RA-responsive element, is turned to a thyroid hormone-responsive element in the presence of GREc. These observations suggest that the response pattern of a gene to various stimuli is influenced by very weak binding sites for some transcription factors.
An additional complexity can be introduced by the apparent cell specificity of GR/TR synergism. Although the effect is seen in different cell lines, it is much stronger in the mammary tumor cell lines T47D and MCF-7. It is unclear whether this observation is due to the generally more active transcription machinery in these cell lines or whether it might be related to the mammary carcinoma1 origin of the cells. Possible interplays between identical or different signal transduction pathways have been demonstrated between nuclear receptors and nonreceptor transcription factors binding to adjacent sites (1, 3, 13, 14) . Depending on the factors involved, different domains of the GR are required for synergism: the DBD (18) 
